Point72 Asia Singapore Pte. Ltd. Has $261,000 Holdings in Nu Skin Enterprises, Inc. (NYSE:NUS)

Point72 Asia Singapore Pte. Ltd. decreased its stake in Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) by 49.9% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 37,849 shares of the company's stock after selling 37,712 shares during the quarter. Point72 Asia Singapore Pte. Ltd. owned approximately 0.08% of Nu Skin Enterprises worth $261,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of the business. JPMorgan Chase & Co. raised its holdings in Nu Skin Enterprises by 175.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 231,957 shares of the company's stock worth $1,710,000 after acquiring an additional 147,784 shares during the period. Bank of Montreal Can bought a new position in Nu Skin Enterprises in the 4th quarter worth $80,000. AlphaQuest LLC raised its holdings in Nu Skin Enterprises by 197.8% in the 4th quarter. AlphaQuest LLC now owns 108,204 shares of the company's stock worth $746,000 after acquiring an additional 71,864 shares during the period. MetLife Investment Management LLC raised its holdings in Nu Skin Enterprises by 36.2% in the 4th quarter. MetLife Investment Management LLC now owns 30,429 shares of the company's stock worth $210,000 after acquiring an additional 8,091 shares during the period. Finally, Barclays PLC raised its holdings in Nu Skin Enterprises by 363.8% in the 3rd quarter. Barclays PLC now owns 85,437 shares of the company's stock worth $629,000 after acquiring an additional 67,016 shares during the period. Institutional investors own 82.84% of the company's stock.

Nu Skin Enterprises Stock Performance

NYSE NUS traded up $0.14 during midday trading on Tuesday, hitting $7.59. The company had a trading volume of 340,452 shares, compared to its average volume of 834,442. The company has a quick ratio of 1.17, a current ratio of 1.82 and a debt-to-equity ratio of 0.56. The stock has a market cap of $375.04 million, a price-to-earnings ratio of -2.57 and a beta of 0.92. The firm has a fifty day simple moving average of $6.66 and a two-hundred day simple moving average of $7.00. Nu Skin Enterprises, Inc. has a fifty-two week low of $5.32 and a fifty-two week high of $13.90.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The company reported $0.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.15 by $0.08. Nu Skin Enterprises had a negative net margin of 8.46% and a positive return on equity of 5.86%. The company had revenue of $364.49 million for the quarter, compared to analyst estimates of $352.06 million. Equities analysts forecast that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current fiscal year.

Nu Skin Enterprises Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, June 11th. Stockholders of record on Friday, May 30th will be given a dividend of $0.06 per share. The ex-dividend date of this dividend is Friday, May 30th. This represents a $0.24 annualized dividend and a dividend yield of 3.16%. Nu Skin Enterprises's dividend payout ratio (DPR) is currently -30.00%.

Analyst Ratings Changes

Separately, StockNews.com upgraded shares of Nu Skin Enterprises from a "hold" rating to a "buy" rating in a research report on Monday, May 12th.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.